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We present a case of immediate abdominal wall reconstruction with biologic mesh following the resection of locally advanced
colonic cancer. The tumor in the right colon did not respond to neoadjuvant chemotherapy. Surgical enbloc excision, including
excision of the invasion in the abdominal wall, was achieved, and the defect was reconstructed with porcine dermal collagen mesh.
The patient was discharged with no complication, and adaptation of the mesh was excellent at the six-month followup.
1.Introduction
Complex abdominal wall defects represent a reconstructive
challenge to surgeons. Substantial empirical evidence sug-
gests that the use of prosthetic mesh for the closure
of abdominal wall defects is associated with signiﬁcantly
reduced cumulative recurrence rates after short- and long-
term followup. However, mesh repair of the abdominal
wall defect, particularly synthetic mesh repair, is associated
with several postimplantation complications, such as wound
infections, mesh infections, bowel adhesions, and other
complications frequently requiring revision surgery [1].
When repairing an abdominal wall defect, a prosthetic
mesh sometimes needs to be placed directly on the parietal
peritoneum. Although the standard mesh for this purpose is
laminar implant expanded polytetraﬂuoroethylene (PTFE),
itisgraduallybeingreplacedbylaminarcollagen-basedmesh
[2]. In the literature, there are some case reports of the
abdominal wall being reconstructed with biologic mesh after
surgicalexcisionoftheareainvadedbymalignanttumorcells
[3].
We herein present a case of immediate abdominal wall
reconstruction with porcine dermal collagen mesh following
the resection of locally advanced colon cancer.
2. Case Presentation
A 42-year-old man admitted to the hospital complaining
of a painful abdominal mass and pain in the right lower
quadrant. There was also serous-purulent discharge through
theskinincisionoverthemass.Hehadundergoneappendec-
tomy via a McBurney incision and an umbilical hernia repair
via midline incision 4 years previously. Histopathology had
revealed inﬂammatory changes with no additional abnor-
malities. Abdominal examination revealed an abdominal
massintherightlowerquadrant.Laboratorydataandtumor
markers were within normal limits. Wound culture results
over the course of one year showed negative discharge. He
declined to undergo the surgical exploration suggested at
a local hospital and was referred to our tertiary reference
hospital. Ultrasound revealed a solid abdominal mass that
was approximately 5cm in diameter, localized near the
cecum and the skin incision. There were mesenteric reactive
nodes, 20mm in maximum diameter. No sign of hernia
was recorded upon performance of the Valsalva maneuver.
An abscess with dense contents was observed. Computed
tomography scan (CT) conﬁrmed the existence of a solid
tumor 7cm in diameter, originating from the cecum and
ileocecal valvula, invading the anterior abdominal wall and2 Case Reports in Medicine
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Figure 1: (a) The ﬁrst CT of the patient before neoadjuvant chemotherapy. Thick arrows show the colonic mass, which invaded adjacent
tissues including skin. (b) There was not enough mass regression after neoadjuvant therapy. (c) Excellent mesh adaptation at 6 months. Thin
arrows highlight the mesh area.
skin. There were pericolonic, paraaortic, and paraceliac
lymph nodes of 2.5cm in maximum diameter (Figure 1(a)).
Colonoscopic investigation revealed an ulcero-vegetative
mass ﬁlling the bottom of the cecum. Multiple biopsies were
obtained, and histopathology revealed adenocarcinoma. The
medical oncology department advised a neoadjuvant FOL-
FOX regimen. The patient could not be given the last cycle
of the treatment because of increasing wound discharge and
fever. Repeat CT demonstrated an inadequate response to
chemotherapy (Figure 1(b)). The patient was then referred
back to the surgical department.
Wide excision of the tumor was planned. A cystoscopic
examination was performed, and a double-J catheter was
applied to the right ureter to facilitate a safe surgical
dissection. The mass and possible intraabdominal margins
were marked before the operation (Figure 2(a)). Preop-
eratively, single dose antibiotic prophylaxis was applied.
Laparotomy revealed a colonic mass invading the anterior
abdominal wall and skin. En bloc resection of the lesion
was achieved (Figure 2(b)). Between the skin and peri-
toneum macroscopically tumour invaded tissues including
skin, subcutaneal adipose tissues, muscles, and fascias were
excised with secure margins while performing standard right
hemicolectomy. After lymphatic dissections were completed,
end-to-side ileotransversostomy was done via two layers
of suturing. The abdominal wall defect was reconstructed
with 20cm × 10cm and 1.5mm thickness porcine dermal
Permacol mesh (Covidien Ltd. Dublin, Ireland; Mansﬁeld,
Massachusetts, US). Mesh ﬁxation was performed with 2/0
prolen separate sutures on the inside of safe abdominal
wall (Figures 2(c) and 2(d)). After surgical procedure two
suction drains were applied before closure of abdomen.
One was placed on the right lower quadrant, over the
mesh in the reconstructed abdominal wall defect area,
and the other one was placed on the left symmetrical
location in the peritoneal cavity (Figure 2(e)). No blood
transfusion was required. Histopathology revealed a mildly
diﬀerentiatedadenocarcinomaof11cmmaximumdiameter.
It had invaded the dermis but not the epidermis. There was
vascular but not neural invasion. Only one lymph node out
of a total of 20 lymph nodes retrieved was found to have
metastasized tumor cells. Peritoneal cytology was negative.
The case was determined as Stage 3-C according to the
TNM system. After beginning of intestinal motility, the
patient was given oral intake on the second postoperative
day. Intraperitoneal drain was removed at the same time.
He was discharged after a four-day uneventful stay. Only
simple analgesics were prescribed. The drainage volume
from the ﬁrst drain was measured daily. It was 100cc and
serous on ﬁrst postoperative day and gradually reduced to
10cc/day on seventh day. Then it was removed. The monthly
follow up observations were planned. There was neither
sign nor symptom of local inﬂammation for six months.
The patient complained of mild pain and paresthesia in
the right lower quadrant and right upper leg during the
ﬁrst month of followup. His neurologic examination wasCase Reports in Medicine 3
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Figure 2: (a) Incisions were marked before surgery. (b) En-bloc resection material after extended right hemicolectomy. (c) Mesh applied
to cover the abdominal wall defect, external view. (d) The mesh was secured with interrupted polypropylene sutures from inside. (e) The
surgery has been completed and the skin closed. (f) Late postoperative view of the abdomen.
normal.There wasno abnormal ﬁnding on lumbar magnetic
resonance imaging and electromyography. Local ultrasound
investigation of the wound revealed no collection. We
observed excellent mesh adaptation with physical and CT
examination at six months postoperatively (Figures 2(f) and
1(c)).
3. Discussion
As herein deﬁned there was a large abdominal wall defect.
Primary closure was impossible, and we had to use a
prosthetic material. Although the eﬃcacy of various biologic
meshes in the abdominal wall reconstruction of complex
ventral hernia has been shown, the performance proﬁle of
various biologic mesh scaﬀolds in terms of hernia-speciﬁc
outcomes such as recurrence, mesh explantation, and mesh
infections has not been examined suﬃciently. Permacol
Biologic Implant (PC) is a porcine dermal collagen implant
from which cells, DNA and RNA, are removed in a gentle
process that is not damaging to the 3D collagen matrix. The
resulting acellular collagen matrix is then cross-linked for
enhanced durability in complex repairs [4]. We chose this
material to reconstruct the abdominal wall defect.
Human-derived, porcine cross-linked, and non-cross-
linked porcine bioprosthetic materials were compared in
Shah et al.’s retrospective study to evaluate the clinical
outcomes of patients who underwent complex ventral hernia
repair with bioprosthetic material. The authors recorded at
least one complication in 72.4% of the patients [1]. Harth
and Rosen reported some major complications associated
with xenograft biologic mesh implantation in abdominal
wall reconstruction. They retrospectively reviewed an FDA
database for reported xenograft-associated adverse events.
They found that cross-linked meshes were associated with
the most adverse event reports to the FDA and concluded
that the ﬁndings from that FDA database review pointed
toward a need to carefully evaluate these products [5]. In our
case there was no problem about application of cross-linked
porcine dermal graft in early postoperative period and after
six months follow up.
Orenstein et al. demonstrated that porcine-derived
meshes induce monocyte/macrophage activation in vitro.4 Case Reports in Medicine
However, chemically crosslinked dermis induced signiﬁ-
cantly higher cytokine expression compared to non-cross-
linked dermis [6]. Jarman-Smith and coworkers investigated
porcine collagen cross-linking, degradation, and the capabil-
ity for ﬁbroblast adhesion and proliferation. They found that
the resistance of the matrix to degradation by collagenases
was gained via chemical crosslinking [7]. Deeken and his
coworkers designed a study to compare the histologic and
biochemical evaluation of crosslinked and non-cross-linked
biologic meshes in a porcine model of ventral incisional
hernia repair. They found that the tensile strengths of sites
repaired with biologic mesh were not impacted by very high
de novo tensile strength/stiﬀness or mesh-speciﬁc variables
such as crosslinking. Although crosslinking distinguishes
biologic meshes in the short-term based on the comparison
of histological features, such as cellular inﬁltration and
neovascularization, many diﬀerences diminish over longer
periods of time. Characteristics other than crosslinking, such
as tissue type and processing conditions, are likely respon-
sible for these diﬀerences [8]. Similar results were found in
Melman et al.’s study [9]. In another prospective pilot study,
Hammond and coworkers investigated the human in vivo
cellular response to cross-linked acellular collagen implants.
They studied tissue biopsies obtained from implants and
found that this type of implant had excellent potential
for tissue reinforcement [10]. We had to remove a large
ﬁeld of abdominal wall including all layers from skin to
peritoneum. Because of this reason prosthetic material that
we thought to apply might exactly touch to intraperitoneal
structures, and we worried about probable adhesions and
their bad results. Theoretical and practical advantages of
PC were well established in the literature [11, 12]. This
material supports growth and ﬁbrinolytic activity of human
mesothelial cells; also this material is well tolerated as a
subcutaneous implant with only a minor chronic inﬂamma-
tory response. All these positive eﬀects of PC mesh make
us to choose it to repair the large abdominal defect of our
case. Porcine-derived biomaterials have typically been used
to repair ventral hernias in clinic and experimental studies
[13].
Abdominal compartment syndrome is a serious life-
threatening condition observed after abdominal closure in
patients with severe wall defects. Similar conditions must
be mentioned in pediatric organ transplant recipients. In
literature PC was used to gain extra abdominal volume
and to prevent the syndrome in these conditions [14]. In
our case the abdominal wall defect was not suitable for
primary closure; therefore PC was used to avoid abdominal
compartment syndrome.
The bacterial clearance of biologic grafts used in hernia
repair was investigated in a rat model. It was found
that biologic grafts, compared to synthetic material, were
better able to clear a Staphylococcus aureus contamination
[15]. Biologic graft was preferred in a subsequent deﬁni-
tive abdominal closure after an apronectomy performed
for damage control in a patient with necrotizing fasciitis
and strangulated umbilical hernia [16]. PC has also been
used for hernia repair in contaminated ﬁelds [17]. Our
presented patient has serous-purulent discharge over the
mass. Even though the wound culture results were neg-
ative, we preferred to use biologic graft in concerning
contamination.
Notably, the treatment of abdominal wall neoplasm,
whether primary or secondary, continues to present a chal-
lenging problem. Treatment typically involves massive soft-
tissue loss; thus, this highly aggressive resection sometimes
generates a large, complex abdominal wall defect. Also, there
is a need for immediate reconstruction, if the vital struc-
tures are exposed. Synthetic mesh such as polypropylene
(PP) is commonly used to repair other trunk defects. As
a result of its macroporous structure, the mesh induces
intense ﬁbrovascular inﬁltration and incorporates into the
surrounding myofascial tissue to provide a strong repair.
However, it is also associated with adhesions to intra-
abdominal viscera and enterocutaneous ﬁstula formation.
Furthermore, it is largely intolerant to infection, particularly
if used in contaminated or infected ﬁelds or in the event of
exposure as a result of dehiscence or breakdown of the over-
lying skin. Abdominal wall tumors sometimes accompany
contamination or infection. Such situations contraindicate
implanting synthetic mesh. In a prospective study, Tang
and coworkers investigated the immediate repair of major
abdominal wall defects after extensive tumor excision in
patients with abdominal wall neoplasm. The authors studied
27 cases, and they concluded that biological mesh was
an ideal alternative to synthetic mesh for abdominal wall
restoration after tumor resection, especially in situations of
infection or contamination [18]. In another study, a total
of 30 patients underwent reconstruction after full-thickness
resection of abdominal wall tumors or tumors of intra-
abdominal organs involving the abdominal wall. Acellular
dermal matrix was used more commonly in the patients
with tumors of gastrointestinal origin; it has been a useful
tooltominimizemorbidityandrecurrenceinthesehigh-risk
patients[19].Ghazietal.retr ospectiv elyreviewedallpatients
who required the reconstruction of complex abdominal
wall defects (165 patients in seven years). Mesh was used
in 81.8% of cases, 77% of those being acellular dermal
matrices. The authors found that the recurrence rate was
similar for synthetic and biomesh reconstructions; however,
the complication rates were higher when synthetic mesh was
used [20].
Our presented case was locally advanced colon cancer
with invaded abdominal wall. Our ﬁrst experience showed
that, according to the results of observations, biologic
meshes can safely be used in repair of large and probable
contaminated abdominal wall defects.
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